Shannon Gibson

I'll research this attorney before drafting the summary.

The initial results point to a court staffer's email, not the attorney. Let me disambiguate carefully.

Multiple attorneys share this name. Let me check the Williams & Connolly site directly and look for the liaison counsel record.

Professional Summary: Shannon Gibson

Important sourcing caveat — apparent misattribution. I was unable to verify a patent litigator named Shannon Gibson at Williams & Connolly. The only "Shannon Gibson" connected to the single tracked matter appears, in the underlying MDL correspondence, as the email address shannon_gibson@wnd.uscourts.gov — i.e., personnel at the U.S. District Court for the Northern District of West Virginia, on whose docket the case sits. In that same correspondence, the Regeneron liaison counsel of record is David I. Berl of Williams & Connolly (680 Maine Ave. S.W., Washington, DC), and the defendant-side liaison roles are held by other counsel. The tracked appearance therefore looks like a data artifact rather than an appearance by a Williams & Connolly attorney of this name. Two other attorneys share the name — Shannon Gibson Konn (Atlanta; products liability and general litigation) and Shannon M. Gibson (Winston & Strawn, San Francisco; not a patent specialist per available profiles) — neither of whom matches the tracked firm or case. No reliable Williams & Connolly biography, bar record, or court docket entry for a "Shannon Gibson" as counsel was found.

Specialty / focus areas (inferred only from the tracked case). The sole tracked matter is Regeneron Pharmaceuticals, Inc. v. Amgen Inc., part of In re Aflibercept Patent Litigation, MDL No. 1:24-md-03103-TSK (N.D. W. Va.). That is a biopharmaceutical/BPCIA biosimilar dispute over Regeneron's EYLEA (aflibercept) franchise, involving defendants Amgen, Mylan/Biocon, Celltrion, Samsung Bioepis, Formycon, and Sandoz. It is Hatch-Waxman/biosimilar patent litigation, not Wi-Fi, software, or mechanical work — but no broader practice pattern can be attributed on a single data point.

Side preference. The tracked record shows one appearance, on the plaintiff side (Regeneron) with zero defendant-side appearances. That is far too thin a sample to establish a genuine plaintiff/prosecution-leaning practice, and the attribution issue above means even that one data point should be treated with caution. Nothing supports characterizing this name as an NPE/PAE-side filer or as a defense-side operating-company specialist.

Firm context and notable outcomes. Williams & Connolly is the only firm listed, associated with the Regeneron MDL. That litigation has produced verifiable results — Regeneron obtained preliminary injunctions against several biosimilar makers, with related appeals consolidated before a single Federal Circuit panel — but there is no sourced evidence tying any of those outcomes to a Shannon Gibson. One Regeneron-related IPR/PGR filing appears on USPTO PTACTS in the same matter, but again no counsel of this name is identified in it. PTAB/IPR experience: no verifiable record; cannot be flagged as regular IPR/PGR practitioner. Bar/education: no reliably sourced bar admissions or law-school record for a Williams & Connolly attorney of this name; omitted.

Bottom line: the profile cannot be responsibly written as a patent-litigation bio on the current record. The single tracked appearance is most consistent with a court-staff email address being captured as counsel. I'd recommend the docket be re-verified against the MDL's counsel of record before this attorney is included in any patent-practice analysis.